In 2023, the Horseracing Integrity and Welfare Unit (HIWU) began enforcement of Horseracing Integrity and Safety Authority’s (HISA) Anti-Doping and Medication Control Program. A2LA’s Competition Animal Drug Testing Laboratory Program is recognized by HIWU, and meets the requirements of their standards.
HIWU has also recently recognized A2LA to accredit participating drug testing laboratories to Integrity and Safety Authority’s (HISA) Equine Analytical Laboratory (HEAL) Requirements. Starting January 1, 2025, competition animal drug testing laboratories will have the option to be assessed to HEAL requirements in addition to ISO/IEC 17025:2017, ILAC G7:04/2021, and applicable A2LA requirements, by their expiration date.
Competition animal drug testing labs can conveniently be assessed to all requirements in a single assessment, effectively meeting HIWU requirements. For more information regarding A2LA’s Competition Animal Drug Testing Laboratory Program, visit our website or contact us at info@A2LA.org.